University of Washington: Infections trials

The registry lists 28 Infections studies with University of Washington as lead sponsor. 3 are open to participants now and 7 have results posted.

Phase 2 4Phase 3 6Phase 4 2No phase 18(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Copper Supplementation in CirrhosisRecruitingNCT07471542Not applicable
• Optimizing Infection Prophylaxis Prior to Shoulder SurgeryRecruitingNCT06464770Not applicable
• SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal InfectionRecruitingNCT05286931Not applicable
• Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)CompletedNCT04328961Phase 2/3Results posted
• Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEPCompletedNCT04050540Phase 4Results posted
• Topical Antibiotic Treatment for Spine Surgical Site InfectionCompletedNCT02776774Results posted
• Infant TB Infection Prevention StudyCompletedNCT02613169Phase 2Results posted
• Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected PersonsCompletedNCT01026454Phase 4Results posted
• Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant CouplesCompletedNCT00557245Phase 3Results posted
• Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract InfectionCompletedNCT00305227Phase 2Results posted
• Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study)CompletedNCT05074719
• Immunogenetic Modulators of Mucosal Protection From HIV-1CompletedNCT03701802
• RESIST-2: 2nd-line ART for HIV-2 InfectionTerminatedNCT03394196Not applicable
• Regional and Seasonal Variations in the Incidence and Causative Organisms for Post-traumatic Wound Infections and Osteomyelitis After Open FracturesTerminatedNCT03064009
• The Added Value of a Mobile Application of Community Case Management on Pediatric Referral Rates in MalawiCompletedNCT02763345Not applicable
• Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in KenyaCompletedNCT01425073Not applicable
• Natural History of Human Papillomavirus (HPV) Infections in Mid-Adult Women (WHIM)CompletedNCT01295242
• Integrated Infectious Disease Capacity-Building EvaluationCompletedNCT01190540Not applicable
• Local Warming of Surgical IncisionsCompletedNCT01026259Phase 3
• HPV Infections in Older WomenCompletedNCT00743392
• Supplemental Perioperative Oxygen to Reduce the Incidence of Post-Cesarean Endometritis and Wound InfectionCompletedNCT00670020Not applicable
• Host Response to Urinary Tract Infection in WomenCompletedNCT00642070
• Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease ProgressionCompletedNCT00507221Not applicable
• High-Risk HPV Infections in Women Aged 25 to 65CompletedNCT00461877
• Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV TransmissionCompletedNCT00194519Phase 3
• Reducing Vaginal Infections in WomenCompletedNCT00170430Phase 3
• Effect of Leukoreduced Blood Transfusions on Infection Following TraumaCompletedNCT00135291Phase 2/3
• Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune ActivationCompletedNCT00130910Not applicable